Source:http://linkedlifedata.com/resource/pubmed/id/17308095
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2007-2-19
|
pubmed:abstractText |
Transition from a sessile epithelial phenotype to a migrating mesenchymal phenotype is a crucial step in transforming growth factor-beta (TGF-beta)-induced pancreatic cancer cell migration and invasion. These profound morphologic and functional alterations are associated with characteristic changes in TGF-beta-regulated gene expression, defined by rapid repression of epithelial markers and a strong and sustained transcriptional induction of mesenchymal markers such as the intermediate filament vimentin. In this study, we have analyzed the role of the transcription factor Sp1 in TGF-beta-induced and Smad-mediated gene regulation during epithelial to mesenchymal transition (EMT) and migration of pancreatic cancer cells. Here, we show that Sp1 is required for TGF-beta-induced EMT, and that this function is especially mediated through transcriptional induction of vimentin. Our results emphasize the functional relevance of vimentin in TGF-beta-induced EMT because prevention of its induction strongly reduces cell migration. Altogether, this study helps to better understand the role of Sp1 in TGF-beta-induced progression of pancreatic cancer. It suggests that Sp1, via transcriptional induction of vimentin, cooperates with activated Smad complexes in mesenchymal transition and migration of pancreatic cancer cells upon TGF-beta stimulation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0008-5472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
67
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1563-70
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:17308095-Cell Line, Tumor,
pubmed-meshheading:17308095-Cell Movement,
pubmed-meshheading:17308095-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:17308095-Humans,
pubmed-meshheading:17308095-Mesoderm,
pubmed-meshheading:17308095-Pancreatic Neoplasms,
pubmed-meshheading:17308095-Promoter Regions, Genetic,
pubmed-meshheading:17308095-RNA, Small Interfering,
pubmed-meshheading:17308095-Sp1 Transcription Factor,
pubmed-meshheading:17308095-Transfection,
pubmed-meshheading:17308095-Transforming Growth Factor beta,
pubmed-meshheading:17308095-Vimentin
|
pubmed:year |
2007
|
pubmed:articleTitle |
Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells.
|
pubmed:affiliation |
Department of Gastroenterology, University of Ulm, 35043 Ulm, Germany.
|
pubmed:publicationType |
Journal Article
|